Yi, Ruolan
Zheng, Jiaoyang
Xu, Zhichao
Wu, Jiayan
Liu, Fangfang
Zheng, Jinxin
Li, Duoyun
Han, Shiqing
Yu, Zhijian
Funding for this research was provided by:
Jiangsu Synergetic Innovation Center for Advanced BioManufacture (XTD 2219)
National Natural Science Foundation of China (National Natural Science Foundation of China)
Guangdong Basic and Applied Basic Research Foundation (2024A1515013276)
Sanming Project of Medicine in Shenzhen (SMGC202305029)
Shenzhen Key Medical Discipline Construction Fund (SZXK06162)
Science, Technology and Innovation Commission of Shenzhen Municipality of basic research funds (JCYJ20220530141810023, JCYJ20220530141614034, JCYJ20220530142006015, JCYJ20240813114518024, KJZD20240903103500002)
Article History
Received: 27 November 2024
Accepted: 11 April 2025
First Online: 29 April 2025
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations and were approved by the Ethics Committee of Shenzhen Nanshan People’s Hospital and the 1964 Helsinki declaration and its later amendments, or comparable ethical standards. All experimental procedures involving human subjects were approved by the institutional ethical committee of Shenzhen Nanshan People’s Hospital. Bacterial strains were obtained from stored samples of hospitalized patients, collected as part of the routine clinical management of patients, according to the national guidelines in China. Therefore, informed consent was not sought, and informed consent waiver was approved by the institutional ethical committee of Shenzhen Nanshan People’s Hospital.
: Not applicable.
: The authors declare no competing interests.